JL Liesveld

563 total citations
13 papers, 446 citations indexed

About

JL Liesveld is a scholar working on Hematology, Physiology and Genetics. According to data from OpenAlex, JL Liesveld has authored 13 papers receiving a total of 446 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hematology, 4 papers in Physiology and 4 papers in Genetics. Recurrent topics in JL Liesveld's work include Platelet Disorders and Treatments (4 papers), Erythrocyte Function and Pathophysiology (4 papers) and Hematological disorders and diagnostics (3 papers). JL Liesveld is often cited by papers focused on Platelet Disorders and Treatments (4 papers), Erythrocyte Function and Pathophysiology (4 papers) and Hematological disorders and diagnostics (3 papers). JL Liesveld collaborates with scholars based in United States. JL Liesveld's co-authors include DH Ryan, MA Lichtman, JM Rowe, JM Rowe, CN Abboud, JK Brennan, JF DiPersio, L.S. Constine, Shirley Eberly and R.A. Brasacchio and has published in prestigious journals such as Blood, Leukemia and Bone Marrow Transplantation.

In The Last Decade

JL Liesveld

13 papers receiving 430 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
JL Liesveld United States 9 242 127 100 93 91 13 446
P Buchinger Austria 13 411 1.7× 136 1.1× 196 2.0× 42 0.5× 53 0.6× 22 632
Yoshikazu Sudo Japan 10 224 0.9× 103 0.8× 131 1.3× 25 0.3× 85 0.9× 14 369
KF Bradstock Australia 10 212 0.9× 114 0.9× 198 2.0× 38 0.4× 35 0.4× 19 524
H P Brezinschek Austria 6 138 0.6× 38 0.3× 223 2.2× 28 0.3× 61 0.7× 9 529
Frances Flug United States 9 142 0.6× 103 0.8× 209 2.1× 33 0.4× 195 2.1× 12 586
Toshiya Sumikuma Japan 12 242 1.0× 90 0.7× 130 1.3× 17 0.2× 68 0.7× 20 384
RP Beveridge United States 6 341 1.4× 61 0.5× 131 1.3× 27 0.3× 60 0.7× 8 510
R. Nayar Canada 9 323 1.3× 178 1.4× 131 1.3× 17 0.2× 35 0.4× 14 563
GH Knitter United States 10 321 1.3× 139 1.1× 152 1.5× 24 0.3× 15 0.2× 11 515
Karl Welte Germany 8 188 0.8× 143 1.1× 156 1.6× 19 0.2× 27 0.3× 17 435

Countries citing papers authored by JL Liesveld

Since Specialization
Citations

This map shows the geographic impact of JL Liesveld's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by JL Liesveld with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites JL Liesveld more than expected).

Fields of papers citing papers by JL Liesveld

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by JL Liesveld. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by JL Liesveld. The network helps show where JL Liesveld may publish in the future.

Co-authorship network of co-authors of JL Liesveld

This figure shows the co-authorship network connecting the top 25 collaborators of JL Liesveld. A scholar is included among the top collaborators of JL Liesveld based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with JL Liesveld. JL Liesveld is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
2.
Liesveld, JL, et al.. (1999). Continuous infusion cyclosporine and nifedipine to day +100 with short methotrexate and steroids as GVHD prophylaxis in unrelated donor transplants. Bone Marrow Transplantation. 24(5). 511–516. 7 indexed citations
3.
Brasacchio, R.A., Shirley Eberly, A. Muhs, et al.. (1998). Autotransplantation for relapsed or refractory Hodgkin’s disease: long-term follow-up and analysis of prognostic factors. Bone Marrow Transplantation. 22(3). 265–271. 45 indexed citations
4.
Rowe, JM & JL Liesveld. (1997). Hematopoietic growth factors in acute leukemia. Leukemia. 11(3). 328–341. 35 indexed citations
5.
Lifton, Richard P., L.S. Constine, CN Abboud, et al.. (1997). Autotransplantation for relapsed or refractory non-Hodgkin’s lymphoma (NHL): long-term follow-up and analysis of prognostic factors. Bone Marrow Transplantation. 19(9). 883–890. 42 indexed citations
6.
Liesveld, JL, et al.. (1993). Expression of integrins and examination of their adhesive function in normal and leukemic hematopoietic cells. Blood. 81(1). 112–121. 132 indexed citations
7.
Liesveld, JL, et al.. (1993). Expression of integrins and examination of their adhesive function in normal and leukemic hematopoietic cells. Blood. 81(1). 112–121. 5 indexed citations
8.
Liesveld, JL, et al.. (1989). Characterization of human marrow stromal cells: role in progenitor cell binding and granulopoiesis. Blood. 73(7). 1794–1800. 6 indexed citations
9.
Liesveld, JL, et al.. (1989). Characterization of human marrow stromal cells: role in progenitor cell binding and granulopoiesis. Blood. 73(7). 1794–1800. 56 indexed citations
10.
Liesveld, JL, JM Rowe, & MA Lichtman. (1987). Variability of the erythropoietic response in autoimmune hemolytic anemia: analysis of 109 cases. Blood. 69(3). 820–826. 10 indexed citations
11.
Liesveld, JL, JM Rowe, & MA Lichtman. (1987). Variability of the erythropoietic response in autoimmune hemolytic anemia: analysis of 109 cases. Blood. 69(3). 820–826. 72 indexed citations
12.
Abboud, CN, et al.. (1986). Lysis of human fibroblast colony-forming cells and endothelial cells by monoclonal antibody (6-19) and complement. Blood. 68(6). 1196–1200. 14 indexed citations
13.
Abboud, CN, et al.. (1986). Lysis of human fibroblast colony-forming cells and endothelial cells by monoclonal antibody (6-19) and complement. Blood. 68(6). 1196–1200. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026